Enfermedades Sistémicas y Envejecimiento

Enfermedades autoinmunes, autoinflamatorias y sistémicas
Cronicidad y envejecimiento
Enfermedad tromboembólica venosa
Telangiectasia hemorrágica hereditaria
Enfermedades minoritarias vasculares y de depósito
Inmunopatías del adulto
Alergología
Drogodependencias y alcoholismo

The prevalence and incidence rate of pulmonary arterial hypertension in systemic sclerosis: Systematic review and meta-analysis.

Rubio-Rivas M, Homs NA, Cuartero D, Corbella X.
AUTOIMMUNITY REVIEWS. 2020 Nov 13:102713. doi: 10.1016/j.autrev.2020.102713.

---

Predicting Clinical Outcome with Phenotypic Clusters in COVID-19 Pneumonia: An Analysis of 12,066 Hospitalized Patients from the Spanish Registry SEMI-COVID-19

Rubio-Rivas M, Corbella X, Mora-Luján JM, Loureiro-Amigo J, López Sampalo A, Yera Bergua C, Esteve Atiénzar PJ, Díez García LF, Gonzalez Ferrer R, Plaza Canteli S, Pérez Piñeiro A, Cortés Rodríguez B, Jorquer Vidal L, Pérez Catalán I, León Téllez M, Martín Oterino JÁ, Martín González MC, Serrano Carrillo de Albornoz JL, García Sardon E, Alcalá Pedrajas JN, Martin-Urda Diez-Canseco A, Esteban Giner MJ, Tellería Gómez P, Ramos-Rincón JM, Gómez-Huelgas R.
JOURNAL OF CLINICAL MEDICINE. 2020 Oct 29;9(11):3488. doi: 10.3390/jcm9113488.

---

Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illness

Rubio-Rivas M, Ronda M, Padulles A, Mitjavila F, Riera-Mestre A, García-Forero C, Iriarte A, Mora JM, Padulles N, Gonzalez M, Solanich X, Gasa M, Suarez-Cuartin G, Sabater J, Perez-Fernandez XL, Santacana E, Leiva E, Ariza-Sole A, Dallaglio PD, Quero M, Soriano A, Pasqualetto A, Koo M, Esteve V, Antoli A, Moreno-Gonzalez R, Yun S, Cerda P, Llaberia M, Formiga F, Fanlo M, Montero A, Chivite D, Capdevila O, Bolao F, Pinto X, Llop J, Sabate A, Guardiola J, Cruzado JM, Comin-Colet J, Santos S, Jodar R, Corbella X.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2020 Dec;101:290-297. doi: 10.1016/j.ijid.2020.09.1486. Epub 2020 Oct 6.

---

Prevalence of sarcopenia in community-dwelling older adults using the updated EWGSOP2 definition according to kidney function and albuminuria : The Screening for CKD among Older People across Europe (SCOPE) study.

Moreno-Gonzalez R, Corbella X, Mattace-Raso F, Tap L, Sieber C, Freiberger E, Kostka T, Guligowska A, Melzer I, Melzer Y, Carlsson AC, Ärnlöv J, Roller-Wirnsberger R, Wirnsberger G, Gil P, Martinez SL, Fabbietti P, Corsonello A, Lattanzio F, Formiga F; SCOPE investigators.
BMC GERIATRICS. 2020 Oct 2;20(Suppl 1):327. doi: 10.1186/s12877-020-01700-x.

---

Direct oral anticoagulants versus vitamin K antagonists in antiphospholipid syndrome: A meta-analysis.

Cerdà P, Becattini C, Iriarte A, Hernández JC, Corbella X, Riera-Mestre A.
EUROPEAN JOURNAL OF INTERNAL MEDICNE. 2020 Sep;79:43-50.

---

Clinical trial to assess tolerability and subrogate efficacy effects of an abbreviated schedule with house dust mites mixture subcutaneous immunotherapy

I AntEpara 1 , A Roger 2 , N Bernedo 3 , R Lleonart 4 , F Rodriguez 5 , B Madariaga 6 , J A Asturias 6 , L Begona 6 , A Martinez 6 , M C Gomez Fernandez 6
EUROPEAN ANNALS OF ALLERGY AND CLINICAL IMMUNOLOGY 2020 Mar 19. doi: 10.23822/EurAnnACI.1764-1489.140. Online ahead of print.

---

PI3K (Phosphatidylinositol 3-Kinase) Activation and Endothelial Cell Proliferation in Patients with Hemorrhagic Hereditary Telangiectasia Type 1.

Iriarte A, Figueras A, Cerdà P, Mora JM, Jucglà A, Penín R, Viñals F, Riera-Mestre A.
CELLS 2019 Aug 24;8(9):971. doi: 10.3390/cells8090971.

---

Influence of potassium levels on one-year outcomes in elderly patients with acute heart failure

Formiga F., Chivite D., Corbella X., Conde-Martel A., Arévalo-Lorido J.C., Trullàs J.C., Silvestre J.P., García S.C., Manzano L., Montero-Pérez-Barquero M., RICA investigators group
EUROPEAN JOURNAL OF INTERNAL MEDICINE (ISSN: 0953-6205) 2019

---

Gastrointestinal Bleeding in Patients with Hereditary Hemorrhagic Telangiectasia: Risk Factors and Endoscopic Findings.

Mora-Luján JM, Iriarte A, Alba E, Sánchez-Corral MÁ, Berrozpe A, Cerdà P, Cruellas F, Ribas J, Castellote J, Riera-Mestre A.
JOURNAL OF CLINICAL MEDICINE. 2019 Dec 28;9(1):82.

---

DClinical features and outcomes in a cohort of patients with immunoglobulin G4-related disease at a university hospital in Spain.

Quero M, Draibe J, Solanich X, Rama I, Gomà M, Martínez-Valenzuela L, Fulladosa X, Cruzado JM, Torras J.
CLINICAL KIDNEY JOURNAL 2019 Apr 16;12(6):829-835. doi: 10.1093/ckj/sfz031.

---

Screening for Chronic Kidney Disease (CKD) among Older People across Europe (SCOPE)

Formiga Pérez, Francesc (Principal Investigator (PI))

Funder:

• ISTITUTO NAZIONALE DI RIPOS (INRCA)

01/05/2015 - 30/04/2019

---

Estudio de alteraciones en vías de señalización del endotelio vascular y su correlación clínica en la Telangiectasia Hemorrágica Hereditaria

Riera Mestre, Antonio (Principal Investigator (PI))

Funder:

• FIS-Instituto de Salud Carlos III

01/01/2018 - 31/12/2020

---

A phase 3, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of two dose levels of BCX7353 as an oral treatment for the prevention of attacks in subjects with hereditary angioedema

Lleonart Bellfill, Ramon (Principal Investigator (PI))

Funder reference:

• BCX7353-302

22/05/2018 - 22/05/2020

---

An open-label study to evaluate the long-term safety of daily oral BCX7353 in subjects with type i and ii hereditary angiodema

Lleonart Bellfill, Ramon (Principal Investigator (PI))

Funder reference:

• BCX7353-204

21/02/2018 - 21/02/2021

---

Protocolo del registro de pacientes con Firazyr (Icatibant outcome survey)

Lleonart Bellfill, Ramon (Principal Investigator (PI))

10/01/2017 - 31/12/2020

---

An open-label study to evaluate the long-term safety of daily oral BCX7353 in subjects with type i and ii heredPragmatic, open-label, single-center, randomized, phase II clinical trial to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus in patients with severe pneumonia secondary to COVID-19: the TACROVID trial protocol

EudraCT Number: 2020-001445-39
Sponsor's Protocol Code Number: TACRO-BELL-COVID
National Competent Authority: Spain - AEMPS